Sales decline 0.52% to Rs 65.62 crore
Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as against net loss of Rs 41.34 crore during the previous quarter ended June 2023. Sales declined 0.52% to Rs 65.62 crore in the quarter ended June 2024 as against Rs 65.96 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales65.6265.96 -1 OPM %15.3813.40 -PBDT7.877.54 4 PBT7.377.26 2 NP6.48-41.34 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
